Cannara Biotech Inc at Canaccord Genuity Global Cannabis Conference Transcript
All right. Thanks, everybody, and thanks for those that are watching online on the webcast. We're going to kick off this track this morning. We're excited to have with us Nick who's the CFO of Cannara Biotech which is a Quebec-based Canadian LP that's done really, really well.
So with that, let me turn over to Nick.
So thank you. Welcome, everyone. Thank you for joining me today. My name is Nicholas Sosiak. I'm the Chief Financial Officer of Cannara Biotech. We are a publicly traded company under the TSXV, ticker L-O-V-E, LOVE, and on the OTCQB, ticker LOVFF.
Before I get into it, I wanted to share three key notes. First one takeaway is why I believe Cannara is going to be successful in Canada and dominate Canada? One is our asset base and our location, allowing us to have the lowest cost of production, being in Quebec. Number two is our value proposition, focused on quality and low price. And third is our management team.
I'm the CFO, but I have -- I'm actually proud to say
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |